California Public Employees Retirement System Catalyst Pharmaceuticals, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$4.29 - $6.05 $846,417 - $1.19 Million	-197,300 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$3.45 - $4.69 $96,531 - $131,226	-27,980 Reduced 12.42%	197,300 $910,000
Q4 2020 Feb 02, 2021	SELL	$2.97 - $3.83 $12,474 - $16,086	-4,200 Reduced 1.83%	225,280 $752,000
Q3 2020 Nov 05, 2020	BUY	$2.97 - $5.08 $1,805 - $3,088	608 Added 0.27%	229,480 $682,000
Q2 2020 Aug 12, 2020	BUY	$3.48 - $5.05 $12,677 - $18,397	3,643 Added 1.62%	228,872 $1.06 Million
Q1 2020 May 12, 2020	BUY	$2.61 - $5.21 $55,071 - $109,931	21,100 Added 10.34%	225,229 $867,000
Q4 2019 Jan 27, 2020	BUY	$3.67 - $5.7 $249,104 - $386,893	67,876 Added 49.82%	204,129 $765,000
Q3 2019 Oct 31, 2019	BUY	$3.89 - $7.43 $273,692 - $522,759	70,358 Added 106.77%	136,253 $724,000
Q2 2019 Aug 15, 2019	BUY	$2.7 - $6.11 $71,180 - $161,077	26,363 Added 66.69%	65,895 $253,000
Q1 2019 May 03, 2019	SELL	$2.11 - $5.33 $36,224 - $91,505	-17,168 Reduced 30.28%	39,532 $202,000
Q3 2018 Nov 13, 2018	BUY	$2.81 - $3.78 $43,184 - $58,091	15,368 Added 37.18%	56,700 $214,000
Q3 2017 Nov 15, 2017	BUY	$2.4 - $2.94 $99,196 - $121,516	41,332	41,332 $104,000

Others Institutions Holding CPRX

# of Institutions

336

Shares Held

95.5M

Call Options Held

19.1K

Put Options Held

51.1K

Black Rock Inc. New York, NY

18.7M
Shares

$437 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

8.04M
Shares

$188 Million
0.0% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

6.23M
Shares

$146 Million
2.3% of portfolio
State Street Corp Boston, MA

5.69M
Shares

$133 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

3.02M
Shares

$70.6 Million
0.01% of portfolio

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.41B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account